HRTS Top Holdings & Constituents
HRTS, offered by Tema, holds 45 reported positions across $54.8M in assets. Its largest holdings are Eli Lilly & Co (LLY) (11.52%), UnitedHealth Group Inc (UNH) (5.24%), and Novo Nordisk A/S (NOVOB) (5.24%). The 5 biggest positions account for 30.77% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
LLY Eli Lilly & Co | 11.52% | $5.98M |
UNH UnitedHealth Group Inc | 5.24% | $2.72M |
NOVOB Novo Nordisk A/S | 5.24% | $2.72M |
RHHBY Roche Holding AG | 4.50% | $2.33M |
MRK Merck & Co Inc | 4.27% | $2.22M |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended May 31, 2026. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.